Engineered white blood cells can eliminate cancer, shows study

by Melissa Pappas,University of PennsylvaniaMacrophages killing cancer cell. Credit: Susan ArnoldBy silencing the molecular pathway that prevents macrophages from attacking our own cells, Univer

Updated on: January 16,2024

Engineered white blood cells can eliminate cancer, shows study

by Melissa Pappas,University of PennsylvaniaMacrophages killing cancer cell. Credit: Susan ArnoldBy silencing the molecular pathway that prevents macrophages from attacking our own cells, Univer

Updated on:January 16,2024

'Double life' of key immune protein reveals new strategies for treating cancer and autoimmune diseases

by NYU Langone HealthCredit: CC0 Public DomainInsights into the workings of an immune cell surface receptor, called PD-1, reveal how treatments that restrict its action can potentially be strengt

Updated on: March 20,2024

'Double life' of key immune protein reveals new strategies for treating cancer and autoimmune diseases

by NYU Langone HealthCredit: CC0 Public DomainInsights into the workings of an immune cell surface receptor, called PD-1, reveal how treatments that restrict its action can potentially be strengt

Updated on:March 20,2024

Turbocharging the body's natural killer cells to defeat cancer

by Monash UniversityDr. Jai Rautela and Professor Nicholas Huntington. Credit: Monash UniversityNatural Killer (NK) cells have long been the soldiers of the immune system that prevents the growth

Updated on: April 18,2024

Turbocharging the body's natural killer cells to defeat cancer

by Monash UniversityDr. Jai Rautela and Professor Nicholas Huntington. Credit: Monash UniversityNatural Killer (NK) cells have long been the soldiers of the immune system that prevents the growth

Updated on:April 18,2024

New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

by BloodwiseCredit: Wikimedia CommonsSurvival times for a highly aggressive type of blood cancer have nearly doubled over the last decade due to the introduction of new targeted drugs, a Yorkshire stu

Updated on: March 12,2024

New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

by BloodwiseCredit: Wikimedia CommonsSurvival times for a highly aggressive type of blood cancer have nearly doubled over the last decade due to the introduction of new targeted drugs, a Yorkshire stu

Updated on:March 12,2024

Study finds specific microbiome tied to long-term survival of patients with pancreatic cancer

by University of Texas M. D. Anderson Cancer CenterFlorencia McAllister, M.D. Credit: MD Anderson Cancer CenterA key difference between the few pancreatic cancer patients who survive long-term an

Updated on: July 04,2024

Study finds specific microbiome tied to long-term survival of patients with pancreatic cancer

by University of Texas M. D. Anderson Cancer CenterFlorencia McAllister, M.D. Credit: MD Anderson Cancer CenterA key difference between the few pancreatic cancer patients who survive long-term an

Updated on:July 04,2024

Researchers uncover potential novel therapeutic targets against natural killer/T-cell lymphoma

by National University of SingaporePotential new therapeutic targets in NKTL. Credit: Dr Jianbiao ZhouA team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the N

Updated on: January 28,2024

Researchers uncover potential novel therapeutic targets against natural killer/T-cell lymphoma

by National University of SingaporePotential new therapeutic targets in NKTL. Credit: Dr Jianbiao ZhouA team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the N

Updated on:January 28,2024

Novel selenium carrier protein regulates ferroptosis in tumors and the brain

byTohoku UniversityPRDX6 is a critical regulator of ferroptosis surveillance. As a selenium- acceptor protein, PRDX6 aids in intracellular selenium utilization for efficient selenoprotein biosyn

Updated on: December 01,2024

Novel selenium carrier protein regulates ferroptosis in tumors and the brain

byTohoku UniversityPRDX6 is a critical regulator of ferroptosis surveillance. As a selenium- acceptor protein, PRDX6 aids in intracellular selenium utilization for efficient selenoprotein biosyn

Updated on:December 01,2024

Study links gut microbiome and aggressive prostate cancer

by Cleveland ClinicCredit: CC0 Public DomainCleveland Clinic researchers have shown for the first time that diet-associated molecules in the gut are associated with aggressive prostate cancer, su

Updated on: April 20,2024

Study links gut microbiome and aggressive prostate cancer

by Cleveland ClinicCredit: CC0 Public DomainCleveland Clinic researchers have shown for the first time that diet-associated molecules in the gut are associated with aggressive prostate cancer, su

Updated on:April 20,2024

Researchers describe a new resistance mechanism

by IDIBELL-Bellvitge Biomedical Research InstituteDue to the treatment with the antibody against Semaphorin 4D (anti-Sema4D), changes occur in the tumor vasculature as well as a decrease in tumor

Updated on: June 08,2024

Researchers describe a new resistance mechanism

by IDIBELL-Bellvitge Biomedical Research InstituteDue to the treatment with the antibody against Semaphorin 4D (anti-Sema4D), changes occur in the tumor vasculature as well as a decrease in tumor

Updated on:June 08,2024

Aging and cancer hallmarks as therapeutic targets

by Compuscript LtdCrosstalk between aging and cancer hallmarks. (a) Aging hallmarks are categorized into five groups based on correlation with cancer hallmarks. (b) Hallmarks shared between aging and

Updated on: January 04,2024

Aging and cancer hallmarks as therapeutic targets

by Compuscript LtdCrosstalk between aging and cancer hallmarks. (a) Aging hallmarks are categorized into five groups based on correlation with cancer hallmarks. (b) Hallmarks shared between aging and

Updated on:January 04,2024

Three doses of COVID-19 mRNA vaccine associated with better outcomes for patients with cancer

byDana-Farber Cancer InstituteForest plot showing results of the multivariable logistic regression analysis following IPTW for the primary endpoint of 30-day mortality among patients with cancer

Updated on: January 03,2024

Three doses of COVID-19 mRNA vaccine associated with better outcomes for patients with cancer

byDana-Farber Cancer InstituteForest plot showing results of the multivariable logistic regression analysis following IPTW for the primary endpoint of 30-day mortality among patients with cancer

Updated on:January 03,2024

Medical scientists describe optimal immune therapeutic strategies for liver cancer

by The Korea Advanced Institute of Science and Technology (KAIST)Schematic image of study. Credit: KAISTKAIST medical scientists have presented a novel pathways involving T immune cell exhaustion

Updated on: May 13,2024

Medical scientists describe optimal immune therapeutic strategies for liver cancer

by The Korea Advanced Institute of Science and Technology (KAIST)Schematic image of study. Credit: KAISTKAIST medical scientists have presented a novel pathways involving T immune cell exhaustion

Updated on:May 13,2024